Comparing Mucinex D vs Zyrtec
| Mucinex D (guaifenesin / pseudoephedrine) | Zyrtec (cetirizine) |
|
|---|
| Mucinex D (guaifenesin / pseudoephedrine) | Zyrtec (cetirizine) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription and OTC
Prescribed for Cough and Nasal Congestion. Mucinex D may also be used for purposes not listed in this medication guide. |
Prescription and OTC
Zyrtec is used to temporarily relieve symptoms due to hay fever or other upper respiratory allergies such as a runny nose, sneezing, itchy or watery eyes, or itching of the nose or throat. It is a... View more |
||||||||||||||||
| More about Mucinex D (guaifenesin / pseudoephedrine) | More about Zyrtec (cetirizine) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Mucinex D has an average rating of 6.1 out of 10 from a total of 224 ratings on Drugs.com. 46% of reviewers reported a positive effect, while 27% reported a negative effect. |
Zyrtec has an average rating of 5.7 out of 10 from a total of 199 ratings on Drugs.com. 43% of reviewers reported a positive effect, while 36% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Mucinex D side effects |
View all Zyrtec side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
N/A |
Lower cost generic approved | ||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Mucinex D prices |
View all Zyrtec prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other guaifenesin / pseudoephedrine brands include: Aldex GS, Altarussin PE, Ambi 60/1000, Ambi 60/580, Ambi 80/780, Ambifed, Ambifed-G, Ami-Tex PSE, Anatuss LA, Aquatab D Dose Pack, Coldmist, Coldmist Jr, Coldmist LA, Congestac, D-Feda II, Deco-D, Decongest II, Deconsal LA, Defen-LA, Degen II, Demibid II, Desal II, Despec-SR, Despec-Tab, Drituss GP, Durasal II, Duratuss GP (old formulation), Dynex, Entex PSE, Entex T, Eudal SR, ExeFen, ExeFen-IR, Fenex-PSE, G-Phed, G-Phed- PD, GP 500, Guai Sudo, Guai-Vent/PSE, Guaibid D, Guaibid D Pediatric, Guaifed, Guaifed-PSE, Guaifenex GP, Guaifenex PSE 120, Guaifenex PSE 60, Guaifenex PSE 80, Guaifenex PSE 85, Guaifenex RX, Guaimax-D, Guaipax PSE, Guaitab, Guaivent (Ethex), Guaivent PD, Guiadrine II, Guiadrine II SR, Guiadrine PSE, Guiadrine PSE 120, Guiatex II, Guiatex II SR, Guiatex PSE, Guiatuss PE, Humibid GC, Mardrops-EX, Maxifed, Mucinex D Maximum Strength, Mucus D, Mucus Relief D, Nalex CR, Nalex Jr, Poly-Vent IR, Robitussin Severe Congestion, Ru-Tuss DE, Sinutab Non Drying, Tusnel Pediatric Drops View more | Other cetirizine brands include: All Day Allergy, All Day Allergy Children's, Aller-Tec, Aller-Tec Children's, Alleroff, Children's Allergy Relief, Equate Allergy Relief, PediaCare Children's 24-Hour Allergy, Quzyttir, Zyrtec Hives View more | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
16 hours |
10.6 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 220 drugs are known to interact with Mucinex D:
|
A total of 254 drugs are known to interact with Zyrtec:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
June 22, 2004 |
N/A |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
|||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.